The management of infertility associated with polycystic ovary syndrome

Reproductive Biology and Endocrinology

Volumn 1, Issue , 2003, Pages

  Homburg, Roy ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATASE INHIBITOR; CHIRO INOSITOL; CLOMIFENE CITRATE; DEXAMETHASONE; FOLLITROPIN; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; GONADOTROPIN; HUMAN MENOPAUSAL GONADOTROPIN; INOSITOL DERIVATIVE; INSULIN; INSULIN SENSITIZING AGENT; LETROZOLE; LUTEINIZING HORMONE; METFORMIN; ORAL CONTRACEPTIVE AGENT; PIOGLITAZONE; RECOMBINANT FOLLITROPIN; ROSIGLITAZONE; UNCLASSIFIED DRUG;

ANOVULATION; BODY WEIGHT DISORDER; CLINICAL PROTOCOL; CLINICAL TRIAL; EMBRYO TRANSFER; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HUMAN; HYPERINSULINEMIA; INCREASED APPETITE; LAPAROSCOPY; LOW DRUG DOSE; MULTIPLE PREGNANCY; OVARY HYPERSTIMULATION; OVARY POLYCYSTIC DISEASE; OVULATION INDUCTION; REVIEW; WEIGHT GAIN; WEIGHT REDUCTION;

FEMALE; FERTILIZATION IN VITRO; HUMANS; INFERTILITY, FEMALE; LAPAROSCOPY; POLYCYSTIC OVARY SYNDROME; WEIGHT LOSS;

EID: 4344588839     PISSN: 14777827     EISSN: None     Source Type: Journal    
DOI: 10.1186/1477-7827-1-109     Document Type: Review

References (62)

1. Adams J, Polson DW, Franks S: Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. Br Med J 1986, 293:355-359.
2. Hull MG: Epidemiology of infertility and polycystic ovarian disease: endocrinological and demographic studies. Gynaecol Endocrinol 1987, 1:235-245.
3. Adams J, Franks S, Polson DW, Mason HD, Abdulwahid N, Tucker M, Morris DV, Price J, Jacobs HS: Multifollicular ovaries: clinical and endocrine features and response to pulsatile gonadotrophin releasing hormone. Lancet 1985, 2:1375-1379.
4. Dunaif A, Segal K, Futterweit W, Dobrjansky A: Profound peripheral resistance independent of obesity in polycystic ovary syndrome. Diabetes 1989, 38:1165-1174.
5. Balen AH, Conway GS, Kaltsas G, Techatrasak K, Manning PJ, West C, Jacobs HS: Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients. Hum Reprod 1995, 10:2107-2111.
6. Legro RS, Finegood D, Dunaif A: A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome. J Clin Endocrinol Metab 1998, 83:2694-2698.
7. Carmina E, Lobo RA: Polycystic ovary syndrome: arguably the most common endocrinopathy is associated with significant morbidity in women. J Clin Endocrinol Metab 1999, 84:1897-1899.
8. Poretsky L, Cataldo NA, Rosenwaks Z, Giudice LA: The insulin-related ovarian regulatory system in health and disease. Endocr Rev 1999, 20:535-582.
9. Homburg R: Adverse effect of luteinizing hormone on fertility: fact or fantasy. Baillieres Clin Obstet Gynaecol 1998, 12:555-563.
10. Dale O, Tanbo T, Haug E, Abyholm T: The impact of insulin resistance on the outcome of ovulation induction with low-dose FSH in women with polycystic ovary syndrome. Hum Reprod 1998, 13:567-570.
11. Hamilton-Fairley D, Kiddy D, Watson H, Paterson C, Franks S: Association of moderate obesity with a poor pregnancy outcome in women with polycystic ovary treated with low dose gonadotrophin. Br J Obstet Gynaecol 1992, 99:128-131.
12. White DM, Polson DW, Kiddy D, Sagle P, Watson H, Gilling-Smith C, Hamilton-Fairley D, Franks S: Induction of ovulation with low-dose gonadotrophins in polycystic ovary syndrome: an analysis of 109 pregnancies in 225 women. J Clin Endocrinol Metab 1996, 81:3821-3824.
13. Kiddy DS, Hamilton-Fairley D, Bush A, Anyaoku V, Reed MJ, Franks S: Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome. Clin Endocrinol 1992, 36:1105-1111.
14. Pasquali R, Antenucci D, Casmirri F, Venturoli S, Paradisi R, Fabbri R, Balestra V, Melchionda N, Barbara L: Clinical and hormonal characteristics of obese amenorrheic hyperandrogenic women before and after weight loss. J Clin Endocrinol Metab 1989, 68:173-179.
15. Clark AM, Ledger W, Galletly C, Tomlinson L, Blaney F, Wang X, Norman RJ: Weight loss results in significant improvement in pregnancy and ovulation rates in anovulatory obese women. Hum Reprod 1995, 10:2705-2712.
16. Gysler M, March CM, Mishell DR, Bailey EJ: A decade's experience with an individualized clomiphene treatment regimen including its effects on the postcoital test. Fertil Steril 1982, 37:161-167.
17. MacGregor AH, Johnson JE, Bunde CA: Further clinical experience with clomiphene citrate. Fertil Steril 1968, 19:616-622.
18. Imani B, Eijkemans MJ, te Velde ER: A nomogram to predict the probability of live birth after clomiphene citrate induction of ovulation in normogonadotropic oligomenorrheic infertility. Fertil Steril 2002, 77:91-97.
19. Franks S, Hamilton-Fairley D: Ovulation Induction:Gonadotrophins. In:Reproductive Endocrinology, Surgery and Technology (Edited by: Adashi EY, Rock JA, Rosenwaks Z). Philadelphia, Lippincott-Raven 1996.
20. Imani B, Eijkemans MJ, te Velde ER, Habbema JD, Fauser BC: Predictors of patients remaining anovulatory during clomiphene citrate induction of ovulation in normogonadotropic oligomenorrheic infertility. J Clin Endocrinol Metab 1998, 83:2361-2365.
21. Homburg R, Armar NA, Eshel A, Adams J, Jacobs HS: Influence of serum luteinizing hormone concentrations on ovulation, conception and early pregnancy loss in polycystic ovary syndrome. Br Med J 1988, 297:1024-2106.
22. Agrawal SK, Buyalos RP: Corpus luteum function and pregnancy rates with clomiphene citrate therapy: comparison of human chorionic gonadotrophin-induced versus spontaneous ovulation. Hum Reprod 1995, 10:328-331.
23. Diamant YZ, Evron S: Induction of ovulation by combined clomiphene citrate and dexamethasone treatment in clomiphene citrate non-responders. Eur J Obstet Gynecol Biol 1981, 11:335-340.
24. Daly DC, Walters CA, Soto-Albors CE, Tohan N, Riddick DH: A randomized study of dexamethasone in ovulation induction with clomiphene citrate. Fertil Steril 1984, 41:844-848.
25. Mitwally MF, Casper RF: Use of aromatase inhibitor for induction of ovulation in patients with an inadequate response to clomiphene citrate. Fertil Steril 2001, 75:305-309.
26. Mitwally MF, Casper RF: Aromatase inhibition improves ovarian response to FSH: a potential option for low responders during ovarian stimulation. Fertil Steril 2001, 75:88-89.
27. Hamilton-Fairley D, Franks S: Common problems in induction of ovulation. Ballieres Clin Obstet Gynaecol 1990, 4:609-625.
28. Homburg R, Levy T, Ben-Rafael Z: A comparative prospective study of conventional regimen with chronic low-dose administration of follicle-stimulating hormone for anovulation associated with polycystic ovary syndrome. Fertil Steril 1995, 63:729-733.
29. Insler V: Gonadotrophin therapy: new trends and insights. Int J Fertil 1988, 33:85-91.
30. Van der Meer M, Hompes P, de Boer J, Schats R, Schoemaker J: Cohort size rather than follicle-stimulating hormone threshold levels determines ovarian sensitivity in polycystic ovary syndrome. J Clin Endocrinol Metab 1988, 83:423-426.
31. Homburg R, Howles CM: Low dose FSH therapy for anovulatory infertility associated with polycystic ovary syndrome: rationale, reflections and refinements. Hum Reprod Update 1999, 5:493-499.
32. Seibel MM, Kamrava MM, McArdle C, Taymor ML: Treatment of polycystic ovarian disease with chronic low dose follicle stimulating hormone: biochemical changes and ultrasound correlation. Int J Fertil 1984, 29:39-43.
33. Polson DW, Mason HD, Saldahna MBY, Franks S: Ovulation of a single dominant follicle during treatment with low-dose pulsatile FSH in women with PCOS. Clin Endocrinol 1987, 26:205-212.
34. Hedon B, Hugues JN, Emperaire JC, Chabaud JJ, Barbereau D, Boujenah A, Howles CM, Truong F: A comparative prospective study of a Chronic low dose versus a conventional ovulation stimulation regimen using recombinant human follicle-stimulating hormone in anovulatory infertile women. Hum Reprod 1998, 13:2688-2692.
35. Schoot BC, Hop WC, de Jong FH, van Dessel TJ, Fauser BC: Initial oestradiol response predicts outcome of exogenous gonadotrophins using a step-down regimen for induction of ovulation in PCOS. Fertil Steril 1995, 64:1081-1087.
36. Van Dessel HJHM, Schoot BC, Schipper I, Dahl KD, Fauser BC: Circulating immunoreactive and bioactive follicle-stimulating hormone concentrations in anovulatory infertile women during gonadotrophin induction of ovulation using a decremental dose regimen. Hum Reprod 1995, 11:101-108.
37. Van Santbrink EJP, Fauser BCJM: Urinary follicle-stimulating hormone for normogonadotropic clomiphene resistant anovulatory infertility: prospective, randomized comparison between low dose step-up and step-down dose regimens. J Clin Endocrinol Metab 1997, 82:3597-3602.
38. Christin-Maitre S, Hugues JN: A comparative randomized multricentric study comparing the step-up versus the step-down protocol in polycystic ovary syndrome. Hum Reprod 2003, 18:1626-1631.
39. Homburg R, Berkovitz D, Levy T, Feldberg D, Ashkenazi J, Ben-Raphael Z: In-vitro fertilization and embryo transfer for the treatment of infertility associated with polycystic ovary syndrome. Fertil Steril 1993, 60:858-863.
40. Homburg R, Levy T, Berkovitz D: GnRH agonist reduces the miscarriage rate for pregnancies conceived in women with polycystic ovary syndrome. Fertil Steril 1993, 59:527-531.
41. Van der Meer M, Hompes PGA, Scheele F: The importance of endogenous feedback for monofollicular growth in low-dose step-up ovulation induction with FSH in PCOS, a randomized study. Fertil Steril 1996, 66:571-576.
42. Homburg R, Eshel A, Kilborn J, Adams J, Jacobs HS: Combined luteinizing hormone releasing hormone analogue and exogenous gonadotrophins for the treatment of infertility associated with polycystic ovaries. Hum Reprod 1990, 5:32-37.
43. Scheele F, Hompes PGA, van der Meer M, Schoute E, Schoemaker J: The effects of a gonadotrophin-releasing hormone agonist on treatment with low dose follicle stimulating hormone in polycystic ovary syndrome. Hum Reprod 1993, 8:699-704.
44. Elkind-Hirsch KE, Webster BW, Brown CP, Vernon MW: Concurrent ganirelix and follitropin-beta therapy is an effective and safe regimen for ovulation induction in women with polycystic ovary syndrome. Fertil Steril 2003, 79:603-607.
45. Velazquez EM, Acosta A, Mendoza SG: Menstrual cyclicity after metformin therapy in polycystic ovary syndrome. Obstet Gynecol 1997, 90:392-395.
46. Fleming R, Hopkinson ZE, Wallace AM, Greer IA, Sattar N: Ovarian function and metabolic factors in women with oligomenorrhea treated with metformin in a randomized double blind placebo-controlled trial. J Clin Endocrinol Metab 2002, 87:569-74.
47. Nestler JE, Jakubowicz DJ, Evans WS, Pasquali R: Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome. N Engl J Med 1998, 338:1876-80.
48. Nestler JE, Stovall D, Akhter N, Iuorno MJ, Jacubwicz DJ: Strategies for the use of insulin-sensitizing drugs to treat infertility in women withpolycystic ovary syndrome. Fertil Steril 2002, 77:209-215.
49. Moghetti P, Castello R, Negri C, Tosi F, Perrone F, Caputo M, Zanolin E, Muggeo M: Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation. J Clin Endocrinol Metab 2000, 85:139-146.
50. Ibanez L, Valls C, Ferrer A, Marcos MV, Rodrigues-Hierro F, de Zegher Fl: Sensitization to insulin induces ovulation in non-obese adolescents with anovulatory hyperandrogenism. J Clin Endocrinol Metab 2001, 16:3595-3598.
51. Vandermolen DT, Ratts VS, Evans WS, Stovall DW, Kauma SW, Nestler JE: Metformin increases the ovulatory rate and pregnancy rate with clomiphene citrate in patients with polycystic ovary syndrome who are resistant to clomiphene citrate alone. Fertil Steril 2001, 75:310-315.
52. De Leo V, la Marca A, Ditto A, Ditto A, Morgante G, Cianci A: Effects of metformin on gonadotropin-induced ovulation women with polycystic ovary syndrome. Fertil Steril 1999, 72:282-285.
53. Stadtmauer LA, Toma SK, Riehl RM, Talbert LM: Metformin treatment of patients with polycystic ovary syndrome undergoing in vitro fertilization improves outcomes and is associated with modulation of the insulin-like growth factors. Fertil Steril 2001, 75:505-509.
54. Homburg R: Should patients with polycystic ovary syndrome be treated with metformin? Hum Reprod 2002, 17:853-856.
55. Glueck CJ, Wang P, Goldenberg N, Sieve-Smith L: Pregnancy outcomes among women with polycystic ovary syndrome treated with metformin. Hum Reprod 2002, 17:2858-2864.
56. Jakubowicz DJ, Iuorno MJ, Jakubowicz S, Roberts KA, Nestler JE: Effects of metformin on early pregnancy loss in the polycystic ovary syndrome. J Clin Endocrinol Metab 2002, 87:524-529.
57. Donesky BW, Adashi EY: Surgical ovulation induction: the role of ovarian diathermy in polycystic ovary syndrome. Baillieres Clin Endocrinol Metab 1996, 10:293-310.
58. Farquhar C, Vandekerkhove P, Lilford R: Laparoscopic "drilling" by diathermy or laser for ovulation induction in anovulatory polycystic ovary syndrome. Cochrane Database Syst Rev 2001, 4:CD001122.
59. Abdel Gadir A, Mowafi RS, Alnaser HMI, Alonezi OM, Shaw RW: Ovarian electrocautery versus human gondotrophins and pure follicle stimulating hormone therapy in the treatment of patients with polycystic ovarian disease. Clin Endocrinol 1990, 33:585-592.
60. Lunde O, Djoseland O, Grottum P: Polycystic ovary syndrome: a follow-up study on fertility and menstrual pattern in 149 patients 15-25 years after ovarian wedge resection. Hum Reprod 2001, 16:1479-1485.
61. Gjonnaess H: Ovarian electrocautery in the teatment of women with polycystic ovary syndrome. Factors affecting results. Acta Obstet Gynecol Scand 1994, 73:1-5.
62. Child TJ, Phillips SJ, Abdul-Jalil AK, Gulekli B, Tan SL: A comparison of in-vitro maturation and in-vitro fertilization for women with polycystic ovaries. Obstet Gynecol 2002, 100:665-670.